| KRAS |
| NRAS |
| |||||||
No mutation | Mutation | P-value | No Mutation | Mutation | P-value | ||||||
N | % | N | % | N | % | N | % | ||||
Age | Less than 60 | 5 | 83.3% | 1 | 16.7% | 0.039 | 4 | 66.7% | 2 | 33.3% | 0.551 |
More than 60 | 3 | 30.0% | 7 | 70.0% | 8 | 80.0% | 2 | 20.0% | |||
Gender | Male | 7 | 70.0% | 3 | 30.0% | 0.039 | 7 | 70.0% | 3 | 30.0% | 0.551 |
Female | 1 | 16.7% | 5 | 83.3% | 5 | 83.3% | 1 | 16.7% | |||
Tumor Size | Less than 5 | 2 | 28.6% | 5 | 71.4% | 0.614 | 7 | 100.0% | 0 | 0.0% | 0.383 |
More than 5 | 6 | 66.7% | 3 | 33.3% | 5 | 55.6% | 4 | 44.4% | |||
Tumor Site | Proximal Colon | 4 | 36.4% | 7 | 63.6% | 0.106 | 8 | 72.7% | 3 | 27.3% | 0.755 |
Distal/Rectum | 4 | 80.0% | 1 | 20.0% | 4 | 80.0% | 1 | 20.0% | |||
Tumor Grade | Well Differentiated | 3 | 100.0% | 0 | 0.0% | 0.014 | 1 | 33.3% | 2 | 66.7% | 0.173 |
Moderately Differentiated | 5 | 62.5% | 3 | 37.5% | 7 | 87.5% | 1 | 12.5% | |||
Poorly Differentiated | 0 | 0.0% | 5 | 100.0% | 4 | 80.0% | 1 | 20.0% | |||
Depth of Invasion (pT) | T1 - T2 | 4 | 57.1% | 3 | 42.9% | 0.614 | 6 | 85.7% | 1 | 14.3% | 0.383 |
T3 - T4 | 4 | 44.4% | 5 | 55.6% | 6 | 66.7% | 3 | 33.3% | |||
Lymph Node Involvement (nT) | Negative | 7 | 63.6% | 4 | 36.4% | 0.106 | 8 | 72.7% | 3 | 27.3% | 0.755 |
Positive | 1 | 20.0% | 4 | 80.0% | 4 | 80.0% | 1 | 20.0% | |||
Distant Metastasis (pM) | No metastasis | 6 | 46.2% | 7 | 53.8% | 0.522 | 11 | 84.6% | 2 | 15.4% | 0.064 |
Metastasis | 2 | 66.7% | 1 | 33.3% | 1 | 33.3% | 2 | 66.7% | |||
TNM | Stage 1 - 2 | 6 | 75.0% | 2 | 25.0% | 0.317 | 6 | 75.0% | 2 | 25.0% | 0.248 |
Stage 3 - 4 | 2 | 25.0% | 6 | 75.0% | 6 | 75.0% | 2 | 25.0% | |||
Mucinous Histology | No | 7 | 77.8% | 2 | 22.2% | 0.012 | 6 | 66.7% | 3 | 33.3% | 0.383 |
Yes | 1 | 14.3% | 6 | 85.7% | 6 | 85.7% | 1 | 14.3% | |||
LVI | Absent | 7 | 53.8% | 6 | 46.2% | 0.522 | 10 | 76.9% | 3 | 23.1% | 0.712 |
Present | 1 | 33.3% | 2 | 66.7% | 2 | 66.7% | 1 | 33.3% | |||
Alive | 8 | 66.7% | 4 | 33.3% | 9 | 75.0% | 3 | 25.0% |